Medicenna Therapeutics Corp. (MDNAF)
OTCMKTS · Delayed Price · Currency is USD
0.6100
-0.0040 (-0.65%)
Jul 24, 2025, 4:00 PM EDT
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of $51.13 million as of July 25, 2025. Its market cap has decreased by -50.51% in one year.
Market Cap
51.13M
Enterprise Value
33.13M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.61
Market Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has increased from 48.70M to 51.13M, an increase of 5.00%. That is a compound annual growth rate of 0.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 51.13M | -42.99% |
| Dec 31, 2024 | 89.69M | 305.00% |
| Dec 29, 2023 | 22.15M | -32.75% |
| Dec 30, 2022 | 32.93M | -63.24% |
| Dec 31, 2021 | 89.58M | -62.05% |
| Dec 31, 2020 | 236.06M | 163.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.35M |
| Glass House Brands | 435.78M |
| CytoDyn | 367.24M |
| Northwest Biotherapeutics | 367.14M |